EOFlow v Insulet (CoA, 29 January 2026)
| Date | 29 January 2026 |
|---|---|
| Court | CoA |
| Division | Luxembourg (LU) |
| Type of action | Application RoP262.2 |
| Case number(s) | UPC_CoA_930/2025 |
| Registry reference | UPC-COA-0000930/2025 |
| Parties | EOFlow Co., Ltd. v. Insulet Corporation |
Official decision (PDF) · UPC registry entry
Case timeline
- 4 February 2026 : EOFlow v Insulet (CoA, 4 February 2026) UPC_CoA_930/2025
- 18 March 2026 : EOFLOW v Insulet (CoA, 18 March 2026) UPC-COA-0000930/2025
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
In EOFlow Co., Ltd.’s appeal against the order of the Milan Central Division of 4 December 2025 (penalty payments imposed in favour of Insulet Corporation, EP 4 201 327), the Court of Appeal orders that the documents lodged by EOFlow as “confidential” be made available to Insulet and its representatives, and refuses to restrict Insulet’s use of the distribution information communicated in compliance with a court order.
Question
Is information communicated in compliance with an order under Art. 67 UPCA implicitly subject to a restriction on use in favour of the party providing it, and may a party lodge documents under the “HC” code without an application under Rule 262A RoP?
Decision
Granting a request under Rule 262.2 RoP does not protect against disclosure to the other party. Only a Rule 262A RoP application does (paragraph 24). There is no implicit limitation on the use of information received as a result of compliance with an order under Art. 67 UPCA and Rule 191 RoP, Rule 262A RoP applies at least mutatis mutandis, and EOFlow, which stated that it would not file such an application, should have done so (paragraphs 25 and 26). Information communicated without restriction is in any event no longer confidential (paragraph 27). Lodging documents under the “HC” code without a simultaneous Rule 262A RoP application has no legal basis (paragraph 29). The remaining requests (register, redaction of decisions, exclusion of the public) will be decided later (paragraph 30).
Key points for practice
- A party ordered to communicate information must file a Rule 262A RoP application before communicating it. Otherwise the other party may use it freely (paragraphs 26 and 27).
- The “HC” code in the case management system may not be used without a simultaneous Rule 262A RoP application (paragraph 29).
Provisions applied
- Agreement on a Unified Patent Court
- Arts 58 and 67
- Rules of Procedure
- Rules 115, 190.1, 191, 262.1(b), 262.2 and 262A
- Case law cited
- Kodak v Fujifilm, Court of Appeal, 14 October 2025 (UPC_CoA_699/2025), Strabag v Swarco Futurit, Court of Appeal, 1 August 2025, UPC_CoA_70/2025, Merz v Viatris, Court of Appeal, 26 January 2026 (UPC_CoA_917/2025), Insulet v A. Menarini, Court of Appeal, 9 January 2025 (UPC_CoA_769/2024, dated 9 January 2024 in the order).
Related decisions
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: UPC Court of Appeal, Supplementary protection certificate (SPC), Biosimilar medicinal product, Launch at risk.
Dhenne Avocats blog: UPC Appeals: What the Numbers Show, Pharmaceutical patents and the UPC: is the Court hostile to them?.
Publications by Matthieu Dhenne: The Launch Letter: How Generics and Biosimilars Should Write to Avoid UPC Urgency (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- defendantInsulet Corporation26 decisions in the corpusFollow this party
- claimantEOFlow Co., Ltd.22 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 29 January 2026 EOFlow v Insulet (CoA, 29 January 2026) Application RoP262.2 · UPC_CoA_930/2025
- 4 February 2026 EOFlow v Insulet (CoA, 4 February 2026) Appeal RoP220.2 · UPC_CoA_930/2025 · appeal, first-instance number cited in the decision
L’appel contre l’ordonnance prononçant une astreinte et fixant les frais est irrecevable faute d’autorisation expresse de la division de première instance. La demande d’effet suspensif est rejetée.
- 18 March 2026 EOFLOW v Insulet (CoA, 18 March 2026) Appeal RoP220.2 · UPC_CoA_930/2025 · appeal, first-instance number cited in the decision
La cour d'appel rejette l'appel d'EOFlow : les informations communiquées à Insulet sans ordonnance au titre de la règle 262A ne sont plus des secrets d'affaires ni des informations confidentielles, aucune limitation implicite d'usage n'existant.
What the record states
- Nature of the act
- Application RoP262.2
- Outcome (Dhenne Avocats summary)
- Les pièces déposées comme confidentielles sont rendues accessibles à l’autre partie et la demande de restriction d’usage est rejetée : les informations communiquées en exécution d’une injonction ne sont protégées que par une demande au titre de la règle 262A.
- Appeal
- Decision of the Court of Appeal.
- Instance
- Court of Appeal decision.
Patents mentioned
EP 4 201 327mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- EOFLOW v Insulet (CoA, 18 March 2026) cited in this record
- EOFlow v Insulet (CoA, 4 February 2026) cited in this record
- Merz Pharmaceuticals v Viatris Santé (CoA, 26 January 2026) cited in this record
- Kodak v Fujifilm (CoA, 14 October 2025) cited in this record
- Insulet v A. Menarini Diagnostics (CoA, APL_64383/2024, 9 January 2025) cited in this record
- TELEFONAKTIEBOLAGET LM ERICSSON v ASUSTek Computer (CFI, UPC_CFI_757/2024, 24 August 2026) cites this decision
- InterDigital VC Holdings v The Walt Disney Company (CFI, 24 July 2026) cites this decision
- InterDigital VC Holdings v The Walt Disney Company (CFI, 16 June 2026) cites this decision
- SharkNinja Operating v Groupe SEB France (CoA, 10 June 2026) cites this decision
- Brita v Wessper (CFI, 27 May 2026) cites this decision
- Canon Kabushiki Kaisha v Katun Germany (CFI, UPC_CFI_351/2024, 30 April 2026) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 4 201 327Fluid delivery device with transcutaneous access tool, insertion mechanism and blood glucose monitoring for use therewith recorded proprietor: Insulet Corp | Mentioned in the analysis (role not qualified) Also mentioned in 25 other decision(s): EOFLOW v Insulet (CFI, 22 July 2025) · EOFLOW v Insulet (CoA, 18 March 2026) · EOFlow v Insulet (CoA, 26 February 2026) · EOFlow v Insulet (CoA, 4 February 2026) · Herbert Smith Freehills Kramer (applicant) in Insulet v EOFLow (CoA, 2 · Insulet v EOFLOW (CFI, 15 October 2025) · EOFLOW v Insulet (CFI, ORD_26828/2025, 5 June 2025) · EOFLOW v Insulet (CFI, 28 May 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.